Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2017 Sep 25;24(1):175–184. doi: 10.1016/j.bbmt.2017.09.013

Figure 3.

Figure 3

Severity of skeletal pain and MTC for second donations that were PBSCs. The severity of maximum skeletal pain (Panel A) and maximum MTC (Panel B) scores measured at baseline, at the time of collection and 1 month, 6 months and 1 year post-collection in people who donated PBSCs once (PBSC only), people whose first and second donations were PBSCs (PBSC-PBSC) and donors whose first donation was marrow and second donation was PBSCs (Marrow-PBSC). Skeletal pain represents pain in at least one of the following sites: back, bone, headache, hip, limb, joint, and neck). The severity of skeletal pain was defined as the maximum grade among these pain sites. The severity of MTC was the highest toxicity level of key symptoms including fever in the absence of signs of infection, fatigue, skin rash, local reactions, nausea, vomiting, anorexia, insomnia, dizziness, and syncope.